Ultragenyx Pharmaceu (RARE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | RARE | AMGN | CELG | GILD | BIIB |
| Company | Ultragenyx Pharmaceu | Amgen Inc | Celgene Corp | Gilead Sciences Inc | Biogen Inc |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 45.52 | 270.63 | 108.01 | 66.58 | 198.97 |
| High | 45.55 | 274.86 | 108.59 | 67.18 | 205.75 |
| Low | 43.61 | 269.64 | 107.27 | 66.36 | 198.97 |
| Last | 44.28 | 273.01 | 108.24 | 67.08 | 201.99 |
| Change | -0.83 | -0.53 | +0.11 | +0.05 | +8.81 |
| % Change | -1.84% | -0.19% | +0.10% | +0.07% | +4.56% |
| Volume | 670,600 | 2,467,100 | 191,230,496 | 8,467,000 | 3,265,600 |
| 20-Day Average Volume | 735,740 | 2,172,705 | 16,188,930 | 6,490,535 | 1,263,995 |
| Previous Close | 45.11 | 273.54 | 108.13 | 67.03 | 193.18 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | No | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 46.48 | 271.55 | 108.17 | 69.07 | 202.16 |
| 20-Day Raw Stochastic | 27.94% | 44.22% | 63.25% | 14.81% | 44.61% |
| 20-Day Relative Strength | 44.67% | 48.18% | 64.69% | 33.12% | 42.70% |
| Weighted Alpha | +2.04 | +11.15 | +46.30 | -20.78 | -34.68 |
| Today's Opinion | 24% Buy | 40% Sell | 100% Buy | 100% Sell | 100% Sell |
| Previous Opinion | 24% Buy | 40% Sell | 100% Buy | 100% Sell | 100% Sell |
| Last Month's Opinion | 56% Buy | 24% Buy | 100% Buy | 88% Sell | 100% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.39% since 04/17/24 | +3.39% since 04/17/24 | -1.97% since 11/13/19 | +0.22% since 04/17/24 | +5.12% since 04/17/24 |
| Low | 41.07 on 04/19/24 | 260.68 on 04/19/24 | 107.27 on 11/20/19 | 65.90 on 04/18/24 | 189.44 on 04/19/24 |
| High | 45.58 on 04/23/24 | 274.86 on 04/24/24 | 110.53 on 11/14/19 | 67.68 on 04/23/24 | 205.75 on 04/24/24 |
| 1-Month | |||||
| %Chg | -3.42% since 03/22/24 | -1.14% since 03/22/24 | +5.14% since 10/18/19 | -7.62% since 03/22/24 | -7.39% since 03/22/24 |
| Low | 41.07 on 04/19/24 | 260.68 on 04/19/24 | 102.40 on 10/21/19 | 65.90 on 04/18/24 | 189.44 on 04/19/24 |
| High | 52.56 on 04/11/24 | 288.57 on 03/28/24 | 110.70 on 11/13/19 | 73.87 on 03/28/24 | 218.26 on 03/25/24 |
| 3-Month | |||||
| %Chg | +1.54% since 01/24/24 | -10.64% since 01/24/24 | +13.63% since 08/20/19 | -15.65% since 01/24/24 | -18.28% since 01/24/24 |
| Low | 41.07 on 04/19/24 | 260.68 on 04/19/24 | 93.41 on 08/23/19 | 65.90 on 04/18/24 | 189.44 on 04/19/24 |
| High | 54.56 on 03/01/24 | 329.72 on 02/05/24 | 110.70 on 11/13/19 | 81.06 on 01/25/24 | 251.99 on 01/31/24 |
| 6-Month | |||||
| %Chg | +37.60% since 10/24/23 | -1.13% since 10/24/23 | +14.14% since 05/20/19 | -14.17% since 10/24/23 | -19.88% since 10/24/23 |
| Low | 31.62 on 10/25/23 | 249.70 on 10/31/23 | 89.08 on 07/23/19 | 65.90 on 04/18/24 | 189.44 on 04/19/24 |
| High | 54.56 on 03/01/24 | 329.72 on 02/05/24 | 110.70 on 11/13/19 | 87.86 on 01/19/24 | 268.30 on 01/03/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 3,712,553 | 146,720,288 | 77,035,920 | 83,457,512 | 28,080,836 |
| Shares Outstanding, K | 82,300 | 536,376 | 711,714 | 1,245,077 | 145,361 |
| Annual Sales | 434,250,000 | 28,190,000,000 | 15,281,000,000 | 27,116,000,000 | 9,835,600,000 |
| Annual Net Income | -606,640,000 | 6,717,000,000 | 4,046,000,000 | 5,665,000,000 | 1,161,100,000 |
| Last Quarter Sales | 127,390,000 | 8,196,000,000 | 4,520,000,000 | 7,114,000,000 | 2,386,300,000 |
| Last Quarter Net Income | -123,190,000 | 767,000,000 | 1,691,000,000 | 1,429,000,000 | 249,700,000 |
| 60-Month Beta | 0.65 | 0.58 | 1.41 | 0.19 | -0.02 |
| Per-Share Information | |||||
| Most Recent Earnings | -1.52 on 02/15/24 | 4.71 on 02/06/24 | 2.99 on 10/31/19 | 1.72 on 02/06/24 | 2.95 on 02/13/24 |
| Latest Earnings Date | 05/02/24 | 05/02/24 | 10/31/19 | 04/25/24 | 04/24/24 |
| Most Recent Dividend | N/A | 2.250 on 02/15/24 | N/A | 0.770 on 03/14/24 | N/A |
| Next Ex-Dividends Date | N/A | 05/16/24 | N/A | 03/14/24 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 14.58 | 10.99 | 9.96 | 13.18 |